SEARCH RESULTS FOR: (*purchase New Brunswick driver*)(712787 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Trel-XPress 100, 10cc is made using demineralized human bone mixed with poloxamer reverse phase medium. Trel-XPress 100 is formulated into a putty form and is provided in a sterile, single use package.
Integra Lifesciences Corporation
XPRES110
In Commercial Distribution

  • M386XPRES1101 ()
  • 10381780112518 ()

  • 10cc
XPRES110

  • Bone matrix implant, human-derived
Trel-X™Gel, 5cc is human bone that has been demineralized and combined with poloxamer reverse phase medium which is formulated into a gel or putty-like form. Trel-X is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXG05
In Commercial Distribution

  • M386TXG051 ()
  • 10381780112501 ()

  • 5cc
TXG05

  • Bone matrix implant, human-derived
Trel-X™Gel, 1cc is human bone that has been demineralized and combined with poloxamer reverse phase medium which is formulated into a gel or putty-like form. Trel-X is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXG01
In Commercial Distribution

  • M386TXG011 ()
  • 10381780112495 ()

  • 1cc
TXG01

  • Bone matrix implant, human-derived
Trel-X™Putty, 10cc is human bone that has been demineralized and combined with poloxamer reverse phase medium which is formulated into a gel or putty-like form. Trel-X is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXP10
In Commercial Distribution

  • M386TXP101 ()
  • 10381780112488 ()

  • 10cc
TXP10

  • Bone matrix implant, human-derived
Trel-X™Putty, 5cc is human bone that has been demineralized and combined with poloxamer reverse phase medium which is formulated into a gel or putty-like form. Trel-X is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXP05
In Commercial Distribution

  • M386TXP051 ()
  • 10381780112471 ()

  • 5cc
TXP05

  • Bone matrix implant, human-derived
Trel-XC Putty, 10cc is a combination of human bone that has been demineralized and cancellous bone mixed with poloxamer reverse phase medium and formulated into a paste or putty-like form. Trel-XC is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXCPY10
In Commercial Distribution

  • M386TXCPY101 ()
  • 10381780112464 ()

  • 10cc
TXCPY10

  • Bone matrix implant, human-derived
Trel-XC Putty, 5cc is a combination of human bone that has been demineralized and cancellous bone mixed with poloxamer reverse phase medium and formulated into a paste or putty-like form. Trel-XC is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXCPY05
In Commercial Distribution

  • M386TXCPY051 ()
  • 10381780112457 ()

  • 5cc
TXCPY05

  • Bone matrix implant, human-derived
Trel-XC Paste, 8cc is a combination of human bone that has been demineralized and cancellous bone mixed with poloxamer reverse phase medium and formulated into a paste or putty-like form. Trel-XC is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXCPA08
In Commercial Distribution

  • M386TXCPA081 ()
  • 10381780112440 ()

  • 8cc
TXCPA08

  • Bone matrix implant, human-derived
Trel-XC Paste, 3cc is a combination of human bone that has been demineralized and cancellous bone mixed with poloxamer reverse phase medium and formulated into a paste or putty-like form. Trel-XC is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXCPA03
In Commercial Distribution

  • M386TXCPA031 ()
  • 10381780112433 ()

  • 3cc
TXCPA03

  • Bone matrix implant, human-derived
Trel-XC Paste, 1cc is a combination of human bone that has been demineralized and cancellous bone mixed with poloxamer reverse phase medium and formulated into a paste or putty-like form. Trel-XC is provided in a sterile, single patient use package.
Integra Lifesciences Corporation
TXCPA01
In Commercial Distribution

  • M386TXCPA011 ()
  • 10381780112426 ()

  • 1cc
TXCPA01

  • Bone matrix implant, human-derived
< 1 ... 854 855 856 857 858 ... 1000 >